1. Home
  2. XNCR vs LIND Comparison

XNCR vs LIND Comparison

Compare XNCR & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • LIND
  • Stock Information
  • Founded
  • XNCR 1997
  • LIND 1979
  • Country
  • XNCR United States
  • LIND United States
  • Employees
  • XNCR N/A
  • LIND N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • LIND Transportation Services
  • Sector
  • XNCR Health Care
  • LIND Consumer Discretionary
  • Exchange
  • XNCR Nasdaq
  • LIND Nasdaq
  • Market Cap
  • XNCR 565.1M
  • LIND 618.2M
  • IPO Year
  • XNCR 2013
  • LIND N/A
  • Fundamental
  • Price
  • XNCR $8.44
  • LIND $12.53
  • Analyst Decision
  • XNCR Buy
  • LIND Strong Buy
  • Analyst Count
  • XNCR 7
  • LIND 4
  • Target Price
  • XNCR $27.50
  • LIND $15.75
  • AVG Volume (30 Days)
  • XNCR 777.2K
  • LIND 320.2K
  • Earning Date
  • XNCR 08-04-2025
  • LIND 08-07-2025
  • Dividend Yield
  • XNCR N/A
  • LIND N/A
  • EPS Growth
  • XNCR N/A
  • LIND N/A
  • EPS
  • XNCR N/A
  • LIND N/A
  • Revenue
  • XNCR $127,228,000.00
  • LIND $670,834,000.00
  • Revenue This Year
  • XNCR N/A
  • LIND $17.04
  • Revenue Next Year
  • XNCR $28.84
  • LIND $9.39
  • P/E Ratio
  • XNCR N/A
  • LIND N/A
  • Revenue Growth
  • XNCR N/A
  • LIND 15.71
  • 52 Week Low
  • XNCR $7.16
  • LIND $6.76
  • 52 Week High
  • XNCR $27.24
  • LIND $14.34
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 47.36
  • LIND 63.91
  • Support Level
  • XNCR $7.93
  • LIND $12.06
  • Resistance Level
  • XNCR $9.48
  • LIND $13.66
  • Average True Range (ATR)
  • XNCR 0.53
  • LIND 0.47
  • MACD
  • XNCR 0.06
  • LIND 0.04
  • Stochastic Oscillator
  • XNCR 43.29
  • LIND 65.63

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About LIND Lindblad Expeditions Holdings Inc.

Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.

Share on Social Networks: